- Trends of Mammography Use in a National Breast Cancer Screening Program, 2004-2008
-
Lim SM, Lee HY, Choi KS, Jun JK, Park EC, Kim Y, Han MA, Oh DK, Shim JI
- KMID: 2165952
- Cancer Res Treat.
- 2010 Dec;42(4):199-202.
PURPOSE: Korea started breast cancer screening as part of the National Cancer Screening Program (NCSP) in 1999. In order to identify under-served groups, we investigated mammography uptake in the National... -
- CITED
-
- Close
- SHARE
-
- Close
- Results of Colorectal Cancer Screening of the National Cancer Screening Program in Korea, 2008
-
Shim JI, Kim Y, Han MA, Lee HY, Choi KS, Jun JK, Park EC
- KMID: 2165951
- Cancer Res Treat.
- 2010 Dec;42(4):191-198.
PURPOSE: This study aims to investigate the current situation of national colorectal cancer screening by analyzing participation rates, positive rates of screening methods and screening rate of secondary screening tests... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Malignant Pericardial Effusion Associated with Recurrence and Survival
-
Kim SH, Kwak MH, Park S, Kim HJ, Lee HS, Kim MS, Lee JM, Zo JI, Ro JS, Lee JS
- KMID: 2165954
- Cancer Res Treat.
- 2010 Dec;42(4):210-216.
PURPOSE: We evaluated clinical outcomes after drainage for malignant pericardial effusion with imminent or overt tamponade. MATERIALS AND METHODS: Between August 2001 and June 2007, 100 patients underwent pericardiocentesis for malignant... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary Sites
-
Kim JH, Rha SY, Kim C, Kim GM, Yoon SH, Kim KH, Kim MJ, Ahn JB, Chung HC, Roh JK, Kim HS
- KMID: 2165955
- Cancer Res Treat.
- 2010 Dec;42(4):217-224.
PURPOSE: We investigated the clinicopathologic information of patients with gastric cancer with multiple primary cancers (GC-MPC) of three or more sites. MATERIALS AND METHODS: Between 1995 and 2009, 105,908 patients were... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
-
Kim GM, Jeung HC, Kim D, Kim JH, Yoon SH, Jung ES, Shin SJ
- KMID: 2165957
- Cancer Res Treat.
- 2010 Dec;42(4):235-238.
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare form of primary liver cancer composed of cells with histopathologic features of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Because of its low incidence,... -
- CITED
-
- Close
- SHARE
-
- Close
- Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide Exposure
-
Kim YI, Yoon JY, Hwang JE, Shim HJ, Bae WK, Cho SH, Chung IJ
- KMID: 2165959
- Cancer Res Treat.
- 2010 Dec;42(4):244-246.
The alkylating agent ifosfamide is an anti-neoplastic used to treat various pediatric and adult malignancies. Its potential urologic toxicities include glomerulopathy, tubulopathy and hemorrhagic cystitis. This report describes a case... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
-
Baek KK, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Cho YB, Yun SH, Kim HC, Lee WY, Chun HK
- KMID: 2165950
- Cancer Res Treat.
- 2010 Dec;42(4):185-190.
PURPOSE: Oxaliplatin-induced chronic peripheral neurotoxicity (OXCPN) manifests as a loss of sensation and dysesthesia in the distal extremities, which may impair daily activities and increase in incidence with the amount... -
- CITED
-
- Close
- SHARE
-
- Close
- Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era
-
Kim NY, Sun JM, Kim YJ, Lee KW, Kim JH, Bang SM, Kim JW, Jeong SH, Lee JS
- KMID: 2165953
- Cancer Res Treat.
- 2010 Dec;42(4):203-209.
PURPOSE: Systemic chemotherapy is the only option for patients with unresectable/metastatic hepatocellular carcinoma (HCC) who are not candidates for local/regional treatment. However, the response to such treatment and survival are... -
- CITED
-
- Close
- SHARE
-
- Close
- The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
-
Kim HY, Hwang JY, Kim SW, Lee HJ, Yun HJ, Kim S, Jo DY
- KMID: 2165956
- Cancer Res Treat.
- 2010 Dec;42(4):225-234.
PURPOSE: AMD3100, an antagonist of the CXCR4 chemokine receptor is soon to be used clinically for the peripheral mobilization of hematopoietic stem cells (HSCs) in patients with multiple myeloma. AMD3100... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Initially Mimicking Cutaneous Lupus Erythematosus
-
Chang HJ, Lee MD, Yi HG, Lim JH, Lee MH, Shin JH, Choi SJ, Moon Y, Nahm CH, Kim CS
- KMID: 2165958
- Cancer Res Treat.
- 2010 Dec;42(4):239-243.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease. The prognosis is poor in most cases with rapid progression despite administering chemotherapy. A 67-year-old man complained of skin rashes... -
- CITED
-
- Close
- SHARE
-
- Close
